| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |